Close Menu

NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Thursday that its fourth quarter revenues rose 65 percent year over year.

The company posted Q4 revenues of $10.9 million, up from $6.6 million in Q4 2017, beating the consensus Wall Street estimate of $9.3 million.

Q4 product revenues rose 83 percent to $7.5 million in 2018 from $4.1 million in Q4 2017. Service and other revenues rose 52 percent to $3.4 million from $2.2 million in the prior year quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.